Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

The recent COVID-19 pandemic is a treatment challenge in the acute infection stage but the recognition of chronic COVID-19 symptoms termed post-acute sequelae SARS-CoV-2 infection (PASC) may affect up to 30% of all infected individuals. The underlying mechanism and source of this distinct immunologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Patterson, Bruce K., Francisco, Edgar B., Yogendra, Ram, Long, Emily, Pise, Amruta, Rodrigues, Hallison, Hall, Eric, Herrera, Monica, Parikh, Purvi, Guevara-Coto, Jose, Triche, Timothy J., Scott, Paul, Hekmati, Saboor, Maglinte, Dennis, Chang, Xaiolan, Mora-Rodríguez, Rodrigo A., Mora, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784688/
https://www.ncbi.nlm.nih.gov/pubmed/35082777
http://dx.doi.org/10.3389/fimmu.2021.746021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784688/
https://www.ncbi.nlm.nih.gov/pubmed/35082777
http://dx.doi.org/10.3389/fimmu.2021.746021

Ejemplares similares